openPR Logo
Press release

Protein Therapeutics Market Size to Reach USD 657.12 billion by 2033, Driven by Chronic Disease Burden and Biologic Innovation

08-07-2026 12:24 PM CET | Chemicals & Materials

Press release from: DataM intelligence 4 Market Research LLP

Protein Therapeutics Market Size

Protein Therapeutics Market Size

According to DataM Intelligence, the global protein therapeutics market size is expected to reach approximately USD 421.6 billion by 2026 and USD 580.6 billion by 2031, ultimately reaching USD 657.12 billion by 2033, expanding at a CAGR of 6.6% during 2025-2033. The protein therapeutics market trends are being influenced by the rising prevalence of chronic diseases, advances in biotechnology, increasing adoption of targeted treatments, and the integration of artificial intelligence and machine learning into protein science.
Technologies that support protein structure prediction, protein stability analysis, protein interaction assessment, and personalized medicine are creating new opportunities for therapeutic development. Growing demand for treatments for cancer, diabetes, autoimmune conditions, cardiovascular disorders, and other complex diseases is also supporting continued investment in protein-based medicines.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for Quick Response): https://www.datamintelligence.com/download-sample/protein-therapeutics-market?akash

Recent Developments
• Invivyd, Inc. - 2025: Announced the formation of the SPEAR Study Group, a clinical and translational research team focused on understanding the biology and clinical effects associated with chronic exposure to SARS-CoV-2 or mRNA vaccine-derived spike protein. The group is expected to guide clinical trials evaluating broadly neutralizing anti-SARS-CoV-2 spike protein monoclonal antibody therapies.
• Signify Bio - 2025: Launched with an oversubscribed USD15 million initial financing round to advance its protein therapeutics approach using the body's cellular machinery.
• Akeso Inc. - 2025: Announced that the first patient had been dosed in the registrational Phase II AK130-202 study. The study evaluates AK130, a TIGIT/TGF-β bifunctional antibody fusion protein, in combination with ivonescimab for locally advanced or metastatic pancreatic cancer.

Mergers & Acquisitions
• Invivyd, Inc. - 2025: Formation of the SPEAR Study Group for clinical and translational research into spike protein exposure and monoclonal antibody therapies.
• Signify Bio - 2025: Secured USD15 million in initial financing, with participation from Actium Group, Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, BrightEdge, and the venture capital arm of the American Cancer Society.
• Akeso Inc. - 2025: Advanced the AK130 clinical development program through the Phase II AK130-202 study in combination with ivonescimab.

Protein Therapeutics Market Segmentation
By Product Type
• Monoclonal Antibodies
• Blood Clotting Factors
• Insulin
• Fusion Protein
• Human Growth Hormone
• Follicle Stimulating Hormone
• Others
By Application
• Oncology
• Hormonal Disorders
• Genetic Disorders
• Metabolic Disorders
• Immunologic Disorders
• Hematological Disorders
• Others
By End User
• Pharmaceutical Companies
• Research Organizations
• Academic Institutes
• Others
By Region
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Regional Analysis - Europe
The growing prevalence of chronic diseases across European countries is increasing demand for advanced therapies. Government initiatives supporting innovative medicines and continued investment in biotechnology are also creating favorable conditions for protein-based treatment development. Germany is highlighted as a significant European market because of its strong pharmaceutical manufacturing capabilities, high healthcare expenditure, and strategic investment in biotechnology.
Its focus on clinical research and innovation supports the development and adoption of advanced biologic therapies. Europe's established healthcare infrastructure and pharmaceutical ecosystem provide a strong foundation for continued adoption of protein-based medicines. At the same time, increasing investment in research and personalized treatment approaches is creating opportunities for companies developing next-generation therapies.

Competitive Landscape
The competitive environment includes major pharmaceutical and healthcare companies with established research capabilities, extensive biologics portfolios, manufacturing infrastructure, and global commercial networks.
Top 5 Key Players
• Amgen Inc.
• Abbott Laboratories
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson
Speak to Our Analyst and Get Customization in the Report as per Your Requirements: https://www.datamintelligence.com/customize/protein-therapeutics-market?akash

Conclusion
The global protein therapeutics sector is positioned for continued expansion as healthcare systems increasingly seek targeted treatments for chronic, complex, and life-threatening diseases. The growing prevalence of cancer, diabetes, cardiovascular conditions, autoimmune disorders, and other chronic diseases is creating sustained demand for biologic medicines. Monoclonal antibodies remain the leading product category, while oncology represents the largest application segment.
North America holds the leading regional position, whereas Europe remains a major market supported by established healthcare infrastructure, pharmaceutical capabilities, and biotechnology investment. Asia-Pacific is identified as the fastest-growing region, supported by expanding healthcare access and increasing biotechnology investment. Technological advances are expected to play an increasingly important role in future development. Protein engineering, recombinant technologies, personalized medicine, and AI-supported protein research can help companies develop more targeted and effective therapies.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=protein-therapeutics-market?akash

Industry Related Reports:
Ataxia Market Size
The global Ataxia Market reached USD 2.38 billion in 2025 and is expected to reach USD 6.71 billion by 2035, growing at a CAGR of 10.9% during 2026-2035. Growing demand for disease-modifying treatments, genetic diagnosis, specialist care, and long-term monitoring is supporting market growth.
Get More Insights: https://www.datamintelligence.com/research-report/ataxia-market?akash
Synthetic Lethality Drugs Market Growth
The global Synthetic Lethality Drugs Market reached USD 6.42 billion in 2025 and is projected to reach USD 19.58 billion by 2035, expanding at a CAGR of 11.8% during 2026-2035. Growth is supported by PARP inhibitors, biomarker-based combinations, and an expanding pipeline of targeted oncology therapies.
Get More Insights: https://www.datamintelligence.com/research-report/synthetic-lethality-drugs-market?akash

Explore more Japan Reports: https://www.datamintelligence.com/jp-market-research-report?akash

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About Us :
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Protein Therapeutics Market Size to Reach USD 657.12 billion by 2033, Driven by Chronic Disease Burden and Biologic Innovation here

News-ID: 4598088 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Lawful Interception Market Size Reaches USD 62,330.7 Million in 2033 Driven by Cloud and 5G Technologies
Lawful Interception Market Size Reaches USD 62,330.7 Million in 2033 Driven by C …
According to DataM Intelligence, the lawful interception market reached USD 7,564.2 million in 2026 and is projected to reach USD 62,330.7 million by 2033, registering a CAGR of 30.20% during 2026-2033. The expansion is supported by the increasing need for authorized communication monitoring across mobile and fixed networks, together with growing adoption of digital communication infrastructure. Lawful interception solutions help authorized agencies and communication service providers address legal requirements involving
Global Customer Engagement Solutions Market Size to Hit USD 40.70 Billion by 2033 Amid AI and Cloud Adoption
Global Customer Engagement Solutions Market Size to Hit USD 40.70 Billion by 203 …
According to data intelligence, the global customer engagement solutions market size was valued at USD 25.90 billion in 2025 and is expected to reach USD 40.70 billion by 2033, growing at a CAGR of 10.7% during the forecast period from 2026 to 2033. Customer engagement solutions use data analytics and AI to understand customer preferences, behaviors, and purchase history, helping businesses deliver personalized content, product recommendations, and relevant experiences across
Nano Biotechnology Market Size to Reach USD 335.71 Billion by 2035 as Precision Medicine and Targeted Drug Delivery Drive Growth
Nano Biotechnology Market Size to Reach USD 335.71 Billion by 2035 as Precision …
According to DataM Intelligence, the nano biotechnology market size was valued at USD 148.42 billion in 2025 and is projected to reach USD 335.71 billion by 2035, expanding at a CAGR of 8.10% during 2026-2035. The market is gaining strategic importance as pharmaceutical and biotechnology companies increasingly adopt nanoscale technologies for drug delivery, diagnostics, imaging, gene delivery, and tissue engineering. Key nano biotechnology market trends include the growing use of
Natural Gas Leakage Detection Systems Market Size USD 10.73 Billion by 2033 as Pipeline Expansion and Advanced Detection Drive Growth
Natural Gas Leakage Detection Systems Market Size USD 10.73 Billion by 2033 as P …
According to data intelligence, the global natural gas leakage detection systems market size was valued at USD 6.73 billion in 2025 and is projected to reach USD 10.73 billion by 2033, expanding at a CAGR of 6% during 2026-2033. The market is supported by increasing natural gas production and trade, expanding pipeline infrastructure and storage systems, and the growing need to prevent accidents, environmental damage, and financial losses associated with

All 5 Releases


More Releases for USD

Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery? The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care. In 2025, the global bone cement market was valued at
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine? The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness. In 2025, the global autologous cell therapy
US Ostomy Care and Accessories Market USD 4.03B-USD 6.75B
How Is the United States Ostomy Care and Accessories Market Evolving to Meet the Needs of a Growing Patient Population? The United States Ostomy Care and Accessories Market plays a critical role in improving the quality of life for millions of patients who undergo life-altering surgical procedures involving the digestive or urinary systems. Ostomy care products are essential medical devices designed to manage bodily waste safely and discreetly following surgeries such
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare Introduction: PACS at the Core of Modern Medical Imaging The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making Introduction: The Growing Importance of HEOR in Modern Healthcare The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in